INFUSION: At Your Service, IV Providers Tell Medicare

Why This Topic Matters

Medicare payment policy affects how infusion services are financed, how providers structure care, and whether patients can access home-based IV therapy. Understanding the industry’s arguments and the cost components involved helps readers evaluate reimbursement proposals and their potential impact on service delivery.

Article Sections

1. Industry push for per diem infusion payment

   Summarizes the home-infusion industry’s interest in a per diem model and the rationale presented for revisiting Medicare reimbursement. It also introduces the general payment concepts discussed in the article.

2. White paper and reimbursement policy context

   Describes the association white paper and the broader Medicare policy background referenced in the article. It places the discussion within federal payment and oversight considerations.

3. Service mix and operational cost considerations

   Outlines the types of work home-infusion providers say are involved in delivering therapy and how those activities differ from traditional pharmacy workflows. It also notes the organizational and regulatory context mentioned in the article.